Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scancell develops apoptosis-inducing and anti-growth factor antibodies

Feb. 25, 2002

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Feb. 19, 2002

Hollis-Eden collaborating on development of Aeson's lead compound

Feb. 19, 2002

Compounds that enhance transcription factor AP-1 designed at Active Biotech

Feb. 18, 2002

Phase II trial of CeaVac and TriAb initiated in metastatic colorectal cancer

Feb. 12, 2002

Biomira initiates phase II trial of Theratope vaccine in metastatic colorectal cancer

Feb. 11, 2002

SciClone updates progress of Zadaxin

Feb. 11, 2002

MCA approves phase II study of TTS in pancreatic cancer

Feb. 7, 2002

Fast track designation for Oncophage in metastatic melanoma

Feb. 6, 2002

AltaRex offers further analysis of OvaRex results

Feb. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...